(Q54386232)

29 May 2018

title

Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma. (English)

1 reference

29 May 2018

0 references

1

1 reference

29 May 2018

Tsan-Zon Liu

object named as

Tsan-Zon Liu

6

0 references

author name string

Cheng-Jeng Tai

2

1 reference

29 May 2018

Li-Jen Kuo

3

1 reference

29 May 2018

Po-Li Wei

4

1 reference

29 May 2018

Hung-Hua Liang

5

1 reference

29 May 2018

Weu Wang

7

1 reference

29 May 2018

Chen-Jei Tai

8

1 reference

29 May 2018

Yuan-Soon Ho

9

1 reference

29 May 2018

Chih-Hsiung Wu

10

1 reference

29 May 2018

Ming-Te Huang

11

1 reference

29 May 2018

publication date

23 February 2011

1 reference

29 May 2018

Annals of Surgical Oncology

published in

1 reference

29 May 2018

volume

18

1 reference

29 May 2018

issue

8

1 reference

29 May 2018

page(s)

2395-2403

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-011-1597-3

exact match

0 references

cites work

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Review article: the management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Clinical studies with curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Biological effects of curcumin and its role in cancer chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Apoptotic DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1597-3

10.1245/S10434-011-1597-3

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

Dimensions Publication ID

1027674957

0 references

1 reference

29 May 2018